[Retracted] Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma

Figure 3

The MSRS enables to predict unfavorable outcome in the training dataset. (a) GSEA results confirming the prognostic robustness of the MSRS. (b) Comparison of MSRS scores between patients who were alive () or dead () during follow-up. (c) Kaplan–Meier plot indicating the survival probabilities of HCC patients stratified by their MSRS scores. (d) tROC assessment demonstrating the accuracy of the MSRS for predicting patient survival. (e) Multivariate Cox regression analysis for the validation of the MSRS as a risk factor.

(a)

(b)

(c)

(d)

(e)